Please provide your email address to receive an email when new articles are posted on . Lp(a) is a highly atherogenic particle with no available targeted therapeutics. Screening and targeting ...

Bill Whitaker is an award-winning journalist and 60 Minutes correspondent who has covered major news stories, domestically and across the globe, for more than four decades with CBS News. Payam ...

Learning to play the piano has long been associated with rigid lessons, endless scales, and strict adherence to classical repertoire. Rarely has it been considered fun. But now, Payam Khastkhodaei ...

Heart specialists now recommend that everyone get tested for lipoprotein(a). Here’s what to know about it. The American Heart Association and other cardiac groups now recommend that everyone should be ...

Share on Pinterest A new study suggests elevated lipoprotein(a) levels are linked to residual cardiovascular risk. Image credit: Evgeniia Siiankovskaia/Stocksy A new study suggests that high ...

Novartis, Amgen and Eli Lilly are among the pharmaceutical companies developing drugs to lower levels of a particularly bad form of cholesterol called Lp(a) and potentially prevent heart attacks. Lp(a ...

Production on Netflix‘s A Different World sequel series has concluded in Atlanta, and news of new castings has emerged. Two additional original A Different World cast members will reprise their roles: ...

The Komodo dragon is one of the most formidable predators on Earth, capable of taking down animals far larger than itself. For decades, scientists believed its deadly bite relied on bacteria, but ...

In the early 1960s, Norwegian physician Kåre Berg, M.D., was trying to identify new blood types when he accidentally discovered a lipoprotein with perplexing properties. Similar to cholesterol, but ...

Paul McCartney's 12-song companion album to the new Wings documentary will include three previously unheard songs. Man on the Run: Music from the Motion Picture Soundtrack is set for release on Feb.

LP-284 targets DNA repair defects in cancers, showing promise in preclinical and early clinical trials across multiple cancer types. The FDA's orphan drug designation supports LP-284's development for ...